NHS cuts medicines costs by three quarters of a billion pounds
The NHS has saved more than £700 million from the annual medicines bill to reinvest in new treatments as part of the Long Term Plan.
An NHS-wide campaign has supported patients and doctors to maximise the use of ‘generic’ and best value ‘biologic’ treatments to treat conditions including arthritis and cancer.
New figures show that the uptake of best value medicines lowered costs to taxpayers by £294 million last year alone, on track to meet its ambitious target of a further £400 million annual savings by 2021.
A single drug – adalimumab – treatment for arthritis and other diseases, saved £110 million alone thanks to a ‘smart procurement’, after the drug came off patent at the end of 2018.
Previously adalimumab was the individual medicine on which hospitals spend the most, at a cost of more than £400 million a year.
Simon Stevens, NHS chief executive, recently said:
“The NHS is one of the most efficient health services in the world but as part of the Long Term Plan, we will continue to drive changes to ensure every NHS pound is spent wisely and patients have access to innovative life changing medicines.
“Use of the best value versions of expensive medicines is already delivering effective treatment for patients across the NHS, including those with cancer, offering the right care for patients while saving the tax payer hundreds of millions of pounds.”
The savings for 2018-19 come on top of the £413 million saved from the annual medicines bill in the previous two years by maximising the use of best value generic and biologic treatments.
Taken together the savings mean the campaign to drive take-up has seen more than £700 million freed up to reinvest in other effective medicines.
NHS England has previously announced plans to accelerate and widen the uptake of best value biologic medicines in a bid to save £400 million to £500 million per year by 2020/21.
This money can be then be reinvested in other new, innovative and cost-effective treatments.
These benefits have only been possible by working closely with patients, clinical teams and NHS trusts.
The decision to switch to a best value medicine should always be done in consultation with the patient, through shared decision making.
|Medicine||Treats||2018-2019 savings delivered|
|Adalimumab best value biologic uptake||Rheumatoid diseases, dermatological and inflammatory bowel diseases||£109,668,408|
|Infliximab best value biologic uptake||Rheumatoid diseases and inflammatory bowel diseases||£31,964,413|
|Etanercept best value biologic uptake||Rheumatoid diseases||£36,077,607|
|Rituximab best value biologic uptake||Certain cancers and rheumatoid conditions||£45,174,920|
|Imatinib generic uptake||Types of cancer||£18,848,913|
|Linezolid generic uptake||Types of bacterial infection||£2,037,999|
|Valganciclovir generic uptake||Types of fungal infection||£3,833,955|
|Voriconazole generic uptake||Types of fungal infection||£6,983,219|
|Caspofungin generic uptake||Types of fungal infection||£8,485,062|
|Trastuzumab best value biologic uptake||Breast cancers||£24,254,902|
Latest News from
Response to Scottish Government decision to fund Orkambi and next steps in England13/09/2019 12:10:00
Last month the independent Scottish Medicines Consortium assessed that Vertex’s ‘justification of the treatment’s [Orkambi and Symkevi] costs in relation to its health benefits was not sufficient’: meaning the company was charging an unreasonably high price for its product.
NHS ramps up support for survivors of female genital mutilation (FGM)12/09/2019 16:05:00
Hundreds of survivors of female genital mutilation (FGM) will be able to access expert care, support and treatment earlier thanks to a new network of NHS ‘one stop shop’ clinics being launched today.
Life-changing treatment on the NHS for children with rare, deadly disease11/09/2019 15:20:00
Children in England with a rare condition which leads to early death are set to receive treatment on the NHS, after the health service struck a deal with manufacturers.
NHS violence reduction lead calls for crackdown on knife sales09/09/2019 09:15:00
A leading trauma surgeon has led the call for more to be done to restrict the sale of harmful ‘zombie knives’ to help prevent violent crime.
England’s top nurse to recruit NHS ‘social media influencers’ to extend the reach of NHS App06/09/2019 09:15:00
The search is on for nurses and other health professionals across England to become the face of the NHS App on social media and in their communities, helping people to take back control of their own health.
Dr Nikki Kanani appointed as England’s top family doctor05/09/2019 16:15:00
GP Dr Nikki Kanani is now the country’s top family doctor after being appointed Medical Director for Primary Care for the NHS in England.
NHS to review making statins available direct from pharmacists as part of Long Term Plan to cut heart disease05/09/2019 11:15:00
High dose statins could be made available directly from high street pharmacies as part of the NHS Long Term Plan to cut heart disease and stroke, NHS chief executive Simon Stevens has announced.
‘NHS Passports’ to help staff work flexibly and cut admin costs04/09/2019 14:20:00
Health service staff in England will be able to move seamlessly between sites in a bid to make it easier to take on new roles, plug gaps in staffing and improve patients’ care.